Author pages are created from data sourced from our academic publisher partnerships and public sources.
Some practical problems in implementing randomization
Background While often theoretically simple, implementing randomization to treatment in a masked, but confirmable, fashion can prove difficult in practice. Purpose At least three categories of… Expand
Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer
- C. Anderson, C. Lee, +24 authors J. Buatti
- Journal of clinical oncology : official journal…
- 16 October 2019
PURPOSE Oral mucositis (OM) remains a common, debilitating toxicity of radiation therapy (RT) for head and neck cancer. The goal of this phase IIb, multi-institutional, randomized, double-blind trial… Expand
ROMAN: Reduction in oral mucositis with avasopasem manganese (GC4419)–Phase III trial in patients receiving chemoradiotherapy for locally advanced, nonmetastatic head and neck cancer.
TPS6096Background: Approximately 70% of patients receiving intensity-modulated radiotherapy (IMRT) plus cisplatin for locally advanced head and neck cancer (HNC) develop SOM, defined as WHO Grade 3...
Examining Online Health Sciences Graduate Programs in Canada
Approximately one in 10 employed Canadians worked in health care and social services in 2016. Health professionals perceive life-long learning as an important element of professional life and value… Expand
The Facilitators and Barriers of Physical Activity Engagement For Youth and Young Adults With Childhood Onset Physical Disabilities
- Matt Downs
Tumor Outcomes of Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer